← Leaderboards
Jiadi Xu
Hugo W. Moser Res Inst Kennedy Krieger
$5,875,655
Attributed
$6,849,343
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,849,343 · 7
By mechanism
R01$5,332,884 · 3
R21$1,354,859 · 3
R03$161,600 · 1
Top collaborators
- Wenzhen Duan4 shared
Most similar at Hugo W. Moser Res Inst Kennedy Krieger
Same institution · by research overlap
- Nicholas R Marsh-Armstrong$9,876,161
Others in their field
Other Emerging Leaders on “Magnetic Resonance Imaging”
- Susan Abushakra · Alzheon, Inc.$50,765,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Eric C Palm · Florida State University$31,951,397
- Michael W Rabin · Florida State University$26,502,247
- Ross D McDonald · Florida State University$26,502,247
- Bryan Roth · Univ Of North Carolina Chapel Hill$21,325,531
Research focus
Magnetic Resonance ImagingWaterAlzheimer&AposBrainProteinsImageMouse ModelMetabolicSignal TransductionBaseImaging TechniquesTissuesMeasurementIn VivoEvaluationSuccessPhysiologic PulseTranslatingAnatomyDepositionHuntington DiseasePathologyAmyloid Beta-ProteinGlucose
Grant awards (15)
Cerebrospinal fluid exchange in Alzheimer's disease characterized by advanced MRI techniques$730,594
R01 · FY2025 · AG · contact PI
Emerging role of glymphatic clearance in Huntington's disease$455,052
R01 · FY2025 · NS
Cerebrospinal fluid exchange in Alzheimer's disease characterized by advanced MRI techniques$678,139
R01 · FY2024 · AG · contact PI
Emerging role of glymphatic clearance in Huntington's disease$497,183
R01 · FY2024 · NS
Cerebrospinal fluid exchange in Alzheimer's disease characterized by advanced MRI techniques$710,938
R01 · FY2023 · AG · contact PI
Emerging role of glymphatic clearance in Huntington's disease$530,538
R01 · FY2023 · NS
MRI based phosphocreatine mapping method to assess patients with peripheral arterial disease.$409,328
R01 · FY2023 · HL · contact PI
Altered pH in early Alzheimer's disease detected by creatine chemical exchange saturation transfer MRI$444,314
R21 · FY2022 · AG · contact PI
MRI based phosphocreatine mapping method to assess patients with peripheral arterial disease.$419,993
R01 · FY2022 · HL · contact PI
MRI based phosphocreatine mapping method to assess patients with peripheral arterial disease.$423,225
R01 · FY2021 · HL · contact PI
MRI based phosphocreatine mapping method to assess patients with peripheral arterial disease.$477,894
R01 · FY2020 · HL · contact PI
Imaging brain glucose uptake by onVDMP MRI in Huntington's Disease$464,604
R21 · FY2020 · NS
Impaired Cerebral Glucose Uptake in the Brain as an MRI Marker for Alzheimer' s Disease$445,941
R21 · FY2020 · AG · contact PI
Defining the Ischemic Penumbra by pH Mapping in Acute Ischemia$80,800
R03 · FY2019 · NS · contact PI
Defining the Ischemic Penumbra by pH Mapping in Acute Ischemia$80,800
R03 · FY2018 · NS · contact PI